As of 2025-07-07, the Relative Valuation of Vcanbio Cell & Gene Engineering Corp Ltd (600645.SS) is 6.50 CNY. This relative valuation is based on P/E multiples. With the latest stock price at 25.87 CNY, the upside of Vcanbio Cell & Gene Engineering Corp Ltd based on Relative Valuation is -74.9%.
The range of the Relative Valuation is 5.75 - 7.46 CNY.
| Range | Selected | |
| Trailing P/E multiples | 30.5x - 39.5x | 33.7x |
| Forward P/E multiples | 22.1x - 27.5x | 25.0x |
| Fair Price | 5.75 - 7.46 | 6.50 |
| Upside | -77.8% - -71.2% | -74.9% |
| Date | P/E |
| 2025-04-18 | 112.75 |
| 2025-04-17 | 112.81 |
| 2025-04-16 | 112.17 |
| 2025-04-15 | 115.35 |
| 2025-04-14 | 115.30 |
| 2025-04-11 | 113.13 |
| 2025-04-10 | 111.00 |
| 2025-04-09 | 108.46 |
| 2025-04-08 | 109.78 |
| 2025-04-07 | 113.13 |
| 2025-04-03 | 125.69 |
| 2025-04-02 | 127.82 |
| 2025-04-01 | 129.35 |
| 2025-03-31 | 122.51 |
| 2025-03-28 | 126.76 |
| 2025-03-27 | 119.17 |
| 2025-03-26 | 117.74 |
| 2025-03-25 | 119.81 |
| 2025-03-24 | 122.99 |
| 2025-03-21 | 113.02 |
| 2025-03-20 | 115.41 |
| 2025-03-19 | 116.94 |
| 2025-03-18 | 117.00 |
| 2025-03-17 | 116.57 |
| 2025-03-14 | 118.53 |
| 2025-03-13 | 116.10 |
| 2025-03-12 | 117.37 |
| 2025-03-11 | 118.64 |
| 2025-03-10 | 120.28 |
| 2025-03-07 | 120.66 |
| 2025-03-06 | 115.56 |
| 2025-03-05 | 110.84 |
| 2025-03-04 | 112.75 |
| 2025-03-03 | 110.58 |
| 2025-02-28 | 109.89 |
| 2025-02-27 | 113.07 |
| 2025-02-26 | 113.66 |
| 2025-02-25 | 112.86 |
| 2025-02-24 | 114.82 |
| 2025-02-21 | 117.53 |
| 2025-02-20 | 116.15 |
| 2025-02-19 | 115.19 |
| 2025-02-18 | 113.50 |
| 2025-02-17 | 117.37 |
| 2025-02-14 | 114.98 |
| 2025-02-13 | 110.84 |
| 2025-02-12 | 111.69 |
| 2025-02-11 | 113.92 |
| 2025-02-10 | 115.09 |
| 2025-02-07 | 111.48 |